Platelet microparticles in cryopreserved platelets: Potential mediators of haemostasis

被引:23
|
作者
Johnson, Lacey [1 ]
Raynel, Sarah [1 ]
Seghatchian, Jerard [2 ]
Marks, Denese C. [1 ]
机构
[1] Australian Red Cross Blood Serv, Res & Dev, Sydney, NSW, Australia
[2] Int Consultancy Blood Components Qual Safety Impr, London, England
关键词
Cryopreservation; Platelet; Microparticle; FROZEN-BLOOD PRODUCTS; DIMETHYL-SULFOXIDE; ENDOTHELIAL-CELLS; EXTRACELLULAR MICROPARTICLES; PROCOAGULANT MICROPARTICLES; PROTEOMIC ANALYSIS; PLASMA; ACTIVATION; MEMBRANE; FRESH;
D O I
10.1016/j.transci.2015.10.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet concentrates can be cryopreserved in dimethylsulphoxide (DMSO) and stored at -80 degrees C, which increases the shelf-life from 5 days to up to 4 years. Cryopreserved platelets have been shown to contain a high number of microparticles that have in vitro haemostatic activity. Further, when transfused, cryopreserved platelets have been shown to be at least as haemostatically active, as liquid-stored platelets, if not more so. Given that microparticles are traditionally considered to be pro-coagulant, it is likely that their presence in the cryopreserved component contributes to this haemostatic effect. However, as microparticles are known to mediate many physiological and pathological processes, including in thrombosis and cancer development and progression, further work is warranted to fully understand the functional scope of the microparticles in cryopreserved platelets. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:146 / 152
页数:7
相关论文
共 50 条
  • [21] PLATELETS IN HAEMOSTASIS AND THROMBOSIS
    LUSCHER, EF
    BRITISH JOURNAL OF HAEMATOLOGY, 1967, 13 (01) : 1 - &
  • [23] In vitro comparison of cryopreserved and liquid platelets: potential clinical implications
    Johnson, Lacey
    Reade, Michael C.
    Hyland, Ryan A.
    Tan, Shereen
    Marks, Denese C.
    TRANSFUSION, 2015, 55 (04) : 838 - 847
  • [24] Lipid profile of platelets and platelet-derived microparticles in ovarian cancer
    Hu, Qianghua
    Wang, Miao
    Cho, Min Soon
    Wang, Chunyan
    Nick, Alpa M.
    Thiagarajan, Perumal
    Aung, Fleur M.
    Han, Xianlin
    Sood, Anil K.
    Afshar-Kharghan, Vahid
    BBA CLINICAL, 2016, 6 : 76 - 81
  • [25] DETECTION OF ACTIVATED PLATELETS AND PLATELET-DERIVED MICROPARTICLES FOR CLINICAL DISORDERS
    WU, GX
    LI, JY
    RUAN, CG
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1116 - 1116
  • [26] DIRECT DETECTION OF ACTIVATED PLATELETS AND PLATELET-DERIVED MICROPARTICLES IN HUMANS
    ABRAMS, CS
    ELLISON, N
    BUDZYNSKI, AZ
    SHATTIL, SJ
    BLOOD, 1990, 75 (01) : 128 - 138
  • [27] Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy
    Omoto, S
    Nomura, S
    Shouzu, A
    Hayakawa, T
    Shimizu, H
    Miyake, Y
    Yonemoto, T
    Nishikawa, M
    Fukuhara, S
    Inada, M
    NEPHRON, 1999, 81 (03): : 271 - 277
  • [28] CLEC-2 expression is maintained on activated platelets and on platelet microparticles
    Gitz, Eelo
    Pollitt, Alice Y.
    Gitz-Francois, Jerney J.
    Alshehri, Osama
    Mori, Jun
    Montague, Samantha
    Nash, Gerard B.
    Douglas, Michael R.
    Gardiner, Elizabeth E.
    Andrews, Robert K.
    Buckley, Christopher D.
    Harrison, Paul
    Watson, Steve P.
    BLOOD, 2014, 124 (14) : 2262 - 2270
  • [29] COMPARISON OF PROCOAGULANT AND ANTICOAGULANT ACTIVITIES OF PLATELETS AND PLATELET-DERIVED MICROPARTICLES
    TANS, G
    THOMASSEN, MCLGD
    ZWAAL, RFA
    GRIFFIN, JH
    ROSING, J
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 668 - 668
  • [30] Platelet protein S directly inhibits procoagulant activity on platelets and microparticles
    Stavenuiter, Fabian
    Davis, Nicole F.
    Duan, Erning
    Gale, Andrew J.
    Heeb, Mary J.
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (02) : 229 - 237